High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma

被引：0
|
作者：
Vigouroux, Stephane [1 ]
Gaillard, Fanny [2 ]
Moreau, Philippe [1 ]
Harousseau, Jean-Luc [1 ]
Milpied, Noel [1 ]
机构：
[1] CHU Hotel Dieu, Serv Hematol Clin, 1 Pl Alexis Ricordeau, F-44000 Nantes, France
[2] CHU Hotel Dieu, Lab Anat Pathol, Nantes, France
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We retrospectively investigated the outcome of 30 newly diagnosed patients with mantle cell lymphoma treated with high-dose therapy and autologous stem cell transplantation in first response. With a median follow-up of 55 months, the 5-year overall-survival is 62%, the 5-year progression-free-survival is 40% and no secondary malignancy has occurred.
引用
收藏
页码：1580 / 1582
页数：3
相关论文
共 50 条
  • [1] Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma
    Dreger, P
    vonNeuhoff, N
    Kuse, R
    Sonnen, R
    Glass, B
    Uharek, L
    Bartels, H
    Loffler, H
    Schmitz, N
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 401 - 403
  • [2] High dose therapy and autologous stem cell transplantation in mantle cell lymphoma
    Hiddemann, W
    Dreyling, M
    Parwaresch, R
    Unterhalt, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 49
  • [3] An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma
    Jacobsen, E
    Freedman, A
    CURRENT OPINION IN ONCOLOGY, 2004, 16 (02) : 106 - 113
  • [4] Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
    Roider, Tobias
    Dietrich, Sascha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1811 - 1812
  • [5] THE ROLE OF HIGH-DOSE THERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA
    STEWART, DA
    VOSE, JM
    WEISENBURGER, DD
    ANDERSON, JR
    RUBY, EI
    BAST, MA
    BIERMAN, PJ
    KESSINGER, A
    ARMITAGE, JO
    ANNALS OF ONCOLOGY, 1995, 6 (03) : 263 - 266
  • [6] Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Espinouse, D
    Michallet, AS
    Traulle, C
    Bouafia-Sauvy, F
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    CANCER, 2005, 104 (07) : 1434 - 1441
  • [7] Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
    Mangel, J
    Buckstein, R
    Imrie, K
    Spaner, D
    Crump, M
    Tompkins, K
    Reis, M
    Perez-Ordonez, B
    Deodhare, S
    Romans, R
    Pennell, N
    Robinson, JB
    Hewitt, K
    Richardson, P
    Lima, A
    Pavlin, P
    Berinstein, NL
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 56 - 69
  • [8] Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma
    Laudi, Noel
    Arora, Mukta
    Burns, Linda
    McGlave, Philip
    Miller, Jeffrey
    Bohac, Gerald
    Rogers, Tyson
    Barker, Juliet
    Coad, James
    Weisdorf, Daniel
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 519 - 524
  • [9] High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
    S Ingen-Housz-Oro
    H Bachelez
    O Verola
    C Lebbé
    J P Marolleau
    C Hennequin
    L Dubertret
    P Morel
    C Gisselbrecht
    P Brice
    Bone Marrow Transplantation, 2004, 33 : 629 - 634
  • [10] High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
    Ingen-Housz-Oro, S
    Bachelez, H
    Verola, O
    Lebbé, C
    Marolleau, JP
    Hennequin, C
    Dubertret, L
    Morel, P
    Gisselbrecht, C
    Brice, P
    BONE MARROW TRANSPLANTATION, 2004, 33 (06) : 629 - 634
12345